全文获取类型
收费全文 | 29799篇 |
免费 | 1605篇 |
国内免费 | 741篇 |
专业分类
耳鼻咽喉 | 162篇 |
儿科学 | 786篇 |
妇产科学 | 619篇 |
基础医学 | 1890篇 |
口腔科学 | 532篇 |
临床医学 | 2319篇 |
内科学 | 2781篇 |
皮肤病学 | 228篇 |
神经病学 | 575篇 |
特种医学 | 1109篇 |
外国民族医学 | 2篇 |
外科学 | 12468篇 |
综合类 | 3795篇 |
现状与发展 | 2篇 |
预防医学 | 982篇 |
眼科学 | 120篇 |
药学 | 1780篇 |
48篇 | |
中国医学 | 311篇 |
肿瘤学 | 1636篇 |
出版年
2024年 | 65篇 |
2023年 | 615篇 |
2022年 | 1086篇 |
2021年 | 1367篇 |
2020年 | 1405篇 |
2019年 | 1147篇 |
2018年 | 1047篇 |
2017年 | 845篇 |
2016年 | 932篇 |
2015年 | 1114篇 |
2014年 | 2235篇 |
2013年 | 2159篇 |
2012年 | 1773篇 |
2011年 | 1929篇 |
2010年 | 1517篇 |
2009年 | 1594篇 |
2008年 | 1613篇 |
2007年 | 1547篇 |
2006年 | 1284篇 |
2005年 | 1170篇 |
2004年 | 934篇 |
2003年 | 745篇 |
2002年 | 542篇 |
2001年 | 481篇 |
2000年 | 393篇 |
1999年 | 379篇 |
1998年 | 320篇 |
1997年 | 291篇 |
1996年 | 251篇 |
1995年 | 239篇 |
1994年 | 195篇 |
1993年 | 147篇 |
1992年 | 87篇 |
1991年 | 83篇 |
1990年 | 77篇 |
1989年 | 54篇 |
1988年 | 53篇 |
1987年 | 62篇 |
1986年 | 33篇 |
1985年 | 56篇 |
1984年 | 59篇 |
1983年 | 23篇 |
1982年 | 41篇 |
1981年 | 36篇 |
1980年 | 34篇 |
1979年 | 27篇 |
1978年 | 25篇 |
1977年 | 17篇 |
1976年 | 7篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Jeffrey J. Silbiger 《Echocardiography (Mount Kisco, N.Y.)》2019,36(5):954-957
Secondary tricuspid regurgitation (TR) caused by right ventricular enlargement in the setting of left heart disease/pulmonary hypertension has been well described. In contrast, that associated with right atrial enlargement—atrial functional TR (AF‐TR)—remains largely underappreciated. AF‐TR most often occurs in the setting of lone atrial fibrillation, although it is also seen in its absence (idiopathic AF‐TR). Several recent studies have found that the prevalence, hemodynamic significance, and prognosis of AF‐TR are not inconsequential, suggesting increased physician awareness of this novel clinical entity is warranted. This article discusses the pathogenesis, echocardiographic findings, and treatment of this underappreciated cause of secondary TR. 相似文献
7.
8.
9.
10.
《Journal of vascular surgery》2020,71(6):1921-1929
ObjectiveIdentifying biomarkers for abdominal aortic aneurysms (AAA) could prove beneficial in prognosis of AAA and thus the selection for treatment. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein that is highly expressed in aorta. MFAP4 is involved in several tissue remodeling-related diseases. We aimed to investigate the potential role of plasma MFAP4 (pMFAP4) as a biomarker of AAA.MethodsPlasma samples and data were obtained for 504 male AAA patients and 188 controls in the Viborg Vascular (VIVA) screening trial. The pMFAP4 levels were measured by Alphalisa. The Mann-Whitney U test assessed differences in pMFAP4 levels between the presence and absence of different exposures of interest. The correlation between pMFAP4 and aorta growth rate were investigated through spearman's correlation analysis. Immunohistochemistry and multiple logistic regression adjusted for potential confounders assessed the association between pMFAP4 and AAA. Multiple linear regression assessed the correlation between pMFAP4 and aorta growth rate. Cox regression and competing risk regression were used to investigate the correlation between AAA patients with upper tertile pMFAP4 and the risk of undergoing later surgical repair.ResultsA significant negative correlation between pMFAP4 and aorta growth rate was observed using spearman's correlation analysis (ρ = −0.14; P = .0074). However, this finding did not reach significance when applying multiple linear regression. A tendency of decreased pMFAP4 was observed in AAA using immunohistochemistry. Competing risk regression adjusted for potential confounders indicated that patients with upper tertile pMFAP4 had a hazard ratio of 0.51 (P = .001) for risk of undergoing later surgical repair.ConclusionsHigh levels of pMFAP4 are associated with a decreased likelihood of receiving surgical repair in AAA. This observation warrants confirmation in an independent cohort. 相似文献